While an agency analysis did find signs of Covid “rebound,” the drug significantly reduces hospitalizations and deaths, researchers said.
Category: Drugs (Pharmaceuticals)
-
What to Know About the Recent Eye Drop Recalls
Global Pharma recalled eye drops in February after they were tied to a drug-resistant bacteria strain linked to at least one death. Two more companies have since recalled eye drops.
-
Texas Judge Hears Case to End Federal Approval of Abortion Pill
The judge said he would decide soon whether to issue a preliminary injunction ordering the F.D.A. to withdraw its approval of the drug or wait for the full trial.
-
Novo Nordisk Says It Will Slash the Price of Insulin
The company’s decision follows a similar move by its rival, Eli Lilly, this month.
-
How an Opioid Settlement Hinders Patients’ Access to ADHD Medication and Other Drugs
An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain.
-
F.D.A. Approves New Nasal Spray for Migraines
Pfizer’s treatment applies an approach that is different from some other products, which doctors say may make it safer for people at risk of heart attacks or stroke.
-
Preterm Birth Drug Withdrawn After 12 Years
The F.D.A. seemed poised to rescind approval of Makena, after studies over time indicated the treatment did not halt early childbirth for many women.
-
Walgreens Faces Blowback for Not Offering Abortion Pill in 21 States
The chain’s situation shows the complicated legal and reputational landscape that it and its competitors must navigate in the post-Roe era.
-
Walgreens Says It Won’t Offer the Abortion Pill Mifepristone in Conservative States
The decision applies to 21 states whose attorneys general threatened Walgreens and other pharmacies with legal action if they dispensed the pill there.
-
Opioid Distributors Cleared of Liability to Georgia Families Ravaged by Addiction
The case illustrates the enormous challenges that victims of the opioid crisis have had in getting compensation from the pharmaceutical industry, despite its pledge of billions of dollars to state and local governments.
-
Eli Lilly Says It Will Cut the Price of Insulin
The company said it would cap the monthly out-of-pocket cost of the diabetes drug at $35.